RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial

Add to Collection
RCTs K Sepanjnia, A Modabbernia, M Ashrafi… - …, 2012 - nature.com

Chapter : Section2
Journal Year : 2012
Cited by : 137

… remission rate of 15% in the citalopram group in our study is also comparable to the 7–26% remission … role of pioglitazone in MDD unaccompanied by diabetes and metabolic syndrome. …..... Read More

Keywords : ['moderatetosevere major depressive disorder randomize doubleblind placebocontrolle trial', 'pioglitazone adjunctive therapy']
PubMed Link : https://www.nature.com/articles/npp201258
Google Scholar Link : https://scholar.google.com/scholar?cites=16353858907760007332&as_sdt=5,39&sciodt=0,39&hl=en&num=20